Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98].
Saved in:
| Title: | Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98]. |
|---|---|
| Authors: | Nagaoka K; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA., Bai X; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA; Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150081, Heilongjiang Province, PR China., Ogawa K; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA., Zhang S; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA., Zhou Y; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA; Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang Province, PR China., Carlson RI; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA., Jiang ZG; Sensei Biotherapeutics, Gaithersburg, MD, USA., Fuller S; Sensei Biotherapeutics, Gaithersburg, MD, USA., Lebowitz MS; Sensei Biotherapeutics, Gaithersburg, MD, USA., Ghanbari H; Sensei Biotherapeutics, Gaithersburg, MD, USA., Dong X; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA; Department of Internal Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: dongxi19@msu.edu., Wands JR; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA. |
| Source: | Cancer letters [Cancer Lett] 2026 Jan 16; Vol. 637, pp. 218118. Date of Electronic Publication: 2025 Nov 25. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41298217 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nagaoka+K%22">Nagaoka K</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Bai+X%22">Bai X</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA; Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150081, Heilongjiang Province, PR China.<br /><searchLink fieldCode="AU" term="%22Ogawa+K%22">Ogawa K</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+Y%22">Zhou Y</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA; Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang Province, PR China.<br /><searchLink fieldCode="AU" term="%22Carlson+RI%22">Carlson RI</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+ZG%22">Jiang ZG</searchLink>; Sensei Biotherapeutics, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fuller+S%22">Fuller S</searchLink>; Sensei Biotherapeutics, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lebowitz+MS%22">Lebowitz MS</searchLink>; Sensei Biotherapeutics, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ghanbari+H%22">Ghanbari H</searchLink>; Sensei Biotherapeutics, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Dong+X%22">Dong X</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA; Department of Internal Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: dongxi19@msu.edu.<br /><searchLink fieldCode="AU" term="%22Wands+JR%22">Wands JR</searchLink>; Liver Research Center, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2026 Jan 16; Vol. 637, pp. 218118. <i>Date of Electronic Publication: </i>2025 Nov 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41298217 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.canlet.2025.218118 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 218118 Titles: – TitleFull: Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nagaoka K – PersonEntity: Name: NameFull: Bai X – PersonEntity: Name: NameFull: Ogawa K – PersonEntity: Name: NameFull: Zhang S – PersonEntity: Name: NameFull: Zhou Y – PersonEntity: Name: NameFull: Carlson RI – PersonEntity: Name: NameFull: Jiang ZG – PersonEntity: Name: NameFull: Fuller S – PersonEntity: Name: NameFull: Lebowitz MS – PersonEntity: Name: NameFull: Ghanbari H – PersonEntity: Name: NameFull: Dong X – PersonEntity: Name: NameFull: Wands JR IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 01 Text: 2026 Jan 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1872-7980 Numbering: – Type: volume Value: 637 Titles: – TitleFull: Cancer letters Type: main |
| ResultId | 1 |